NíoSync is a European commercialisation engine serving as the critical bridge between innovative therapies and European patients. We play a unique role in ensuring that patients can access the best lifesaving medicines available and biopharma companies are rewarded fairly for their investment in innovation.

We do this by acquiring the rights to clinically proven medicines to launch and commercialise in European markets through our efficient and flexible infrastructure which is optimised for scale. Our experienced team ensures optimal regulatory and market positioning, leveraging key strategic partnerships for reach and agility.